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Abstract
Background: The source of multipotent stromal cells (MSC) can have a significant influence on the health and
expansion capacity of the cells. As the applications for allogeneic MSCs in the treatment of feline diseases increase,
the location of the initial donor tissue must be analyzed. To date, comparisons have only been made between
feline MSCs collected from bone marrow or abdominal fat. This is the first report to compare cells obtained from
different adipose depots in the cat with a focus on clinically relevant donor tissues. The tissue was collected from 34
healthy cats undergoing spaying (fat around the ovaries and uterine horn) or subcutaneous fat collected during
surgical procedures.
Results: The amount of starting material is essential to isolate sufficient MSCs. The total tissue yield from the
subcutaneous fat was significantly greater than could be obtained from around the reproductive organs, leading to
3 times more MSCs per donor. However, the concentration of MSCs obtained from reproductive fat was higher
than from subcutaneous fat. In addition, the viability of the MSCs from the reproductive fat was significantly higher
than the subcutaneous fat. Since most spaying occurs in young cats (under 18 months) reproductive fat was
collected from adult cats during spaying, illustrating that age did not alter the yield or viability of the MSCs. When
sufficient tissue was collected, it was digested either mechanically or enzymatically. Mechanical digestion further
decreased the viability and yield of MSCs from subcutaneous fat compared to enzymatic digestion. Biomarkers of
stem cell characterization, expansion capacity and function were detected using qPCR. CD70, CD90 and CD105
were all expressed in high levels in the 3 groups. However, the reproductive fat had higher levels of CD73 with the
mechanically digested subcutaneous fat having the least. Gata6 was detected in all samples while Sox2 and Sox17
were also detected with higher quantities found in the enzymatically digested subcutaneous fat. Negative control
genes of Gata4 and Pdx1 showed no detection prior to 50 cycles. During the first three passages, age of the donor,
location of the donor tissue, or digestion protocol had no effect on cell culture doubling times or cell viability.
Conclusions: While MSCs from reproductive fat had superior cells/tissue weight and initial viability, there were still
dramatically fewer cells obtained compared to subcutaneous fat due to the limited amount of tissue surrounding
the reproductive organs. Further, in P1-P3 cultures there were no differences noted in doubling time or cell viability
between tissue obtained from reproductive or subcutaneous fat depots.
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Background
Multipotent stromal cells (MSC) are increasingly
popular in regenerative medicine because of the ease
of access and isolation, ability to self-renew and multipotent potential [1]. These adult stem cells have the
ability to differentiate into cells of the mesodermal
lineage such as adipocytes and osteoblasts, but they
also have transdifferentiation properties allowing them
to be driven to other cell types such as neurons or
myocardial cells [2]. Reports have described the therapeutic application of MSCs to treat various conditions
such as heart failure, inflammatory diseases, musculoskeletal trauma, diabetes and kidney disease [3]. Additionally, MSCs have successfully been used for
treating inflammatory conditions such as osteoarthritis
or graft versus host disease [4].
There are numerous clinical applications for MSCs in
the veterinary field, including the treatment of feline diseases such as gingivostomatitis, inflammatory bowel disease, allergic asthma and chronic kidney disease [5–8].
Research on MSC-based treatment for feline ailments is
expanding our understanding of the potential of stem
cells, along with the challenges associated with feline
cells.
MSCs can be harvested from a variety of sources including adipose tissue, bone marrow, peripheral blood,
and umbilical cord [9, 10]. Cells from diverse sites have
unique properties including basic transcriptome differences and variations in in vitro or in vivo differentiation
[11]. Of the multiple sites from which to obtain MSCs,
adipose tissue is one of the most commonly used and
widely studied. Historically, adipose tissue was considered a simple site of energy storage, but this is no longer
the case. Adipose tissue is a functionally dynamic organ
that is involved in energy homeostasis and the secretion
of several hormones [12].
The abdominal cavity includes several types of adipose
tissue, such as subcutaneous, intramuscular and visceral.
Subcutaneous adipose tissue lies underneath the skin
and is composed of adipocytes that are organized in lobules, separated by connective tissue. Subcutaneous adipose tissue makes up about 80 % of all body fat [13]. In
contrast, visceral adipose tissue is interspersed among
the organs and composed of several different depots including mesenteric, perirenal, and fat surrounding the
reproductive organs. The MSC characteristics can vary
depending on the site of tissue harvest [14]. Reports
demonstrate differences in MSC characteristics when
comparing subcutaneous and visceral adipose tissue surrounding female reproductive tissue obtained during
Caesarean Sections. [15, 16]. Ritter et al. concluded that
human visceral fat associated with the reproductive organs had a higher potential to differentiate into adipogenic and osteogenic cells and secreted higher levels of
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inflammatory cytokines, emphasizing the importance of
the site of tissue harvest [15]. Likewise, research in felines has suggested that reproductive fat may have advantages over other fat depots [17].
While studies have compared feline MSCs obtained
from either bone marrow or fat tissue [18], no study has
compared the different abdominal depots of fat for MSC
retrieval in cats. When considering the translation of this
research to a scaled MSC-based product, we determined
that the tissue source should be easily retrieved as part
of standard veterinary practice from communitydwelling cats when possible. The objective of the study
was to compare feline adipose tissue from subcutaneous
and reproductive organ donor sites to test the hypothesis
that enzymatically digested reproductive fat would result
in higher levels of expansion and multipotent biomarkers along with higher viability and proliferation
capabilities.

Results
Donor Characteristics

The study design was a non-randomized subject sample of convenience with tissue collection occurring
secondary to standard veterinary clinic procedures.
94 % of the procedures were conducted at licensed
veterinary clinics on their clients or at non-profit animal shelters prior to adoption. Only 2 cats were part
of research colonies with fat retrieved during procedures related to the other research studies in which
they were enrolled.
The average age of the donors in the reproductive
group was younger than the subcutaneous group due
to the fact that most spaying occurs in pediatric cats.
However, 7 spayed cats in the reproductive fat group
were over 18 months and thus results of the reproductive fat group were subdivided into pediatric and
adult cats to determine whether the age of the donors
affected the results. Since all veterinary procedures
that allowed the collection of subcutaneous fat occurred on adult cats, there was no pediatric equivalent group. There was no difference in the mean age
of the adult cats in the adult reproductive and subcutaneous tissue groups (Table 1). The average body
weight was less for the pediatric reproductive group
compared to the two adult donor groups (Table 1).
Likewise, the body condition scores were statistically
greater in the adult subcutaneous tissue donors compared to the other groups (Table 1).
All donors in the reproductive fat group were female,
again due to the fact that the fat was obtained during
spaying (Table 1). Donors of subcutaneous fat obtained
from adult cats were approximately 30 % female, leading
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Table 1 Summary of donor characteristics. Fat samples were obtained from healthy cats with the following characteristics.

Age (years)

Pediatric Reproductive Tissue

Adult
Reproductive Tissue

Adult Subcutaneous Tissue

0.38 ± 0.06 #

3.68 ± 0.85

3.81 ± 1.90

Sex (% female)

100 %

100 %

29 %

Donor Body Weight (kg)

2.20 ± 0.02 #

3.57 ± 0.32

4.50 ± 0.44

Body Condition Scores (1 to 5)

3.44 ± 0.31

3.43 ± 0.20

4.50 ± 0.20 *

Average Tissue Weight
(gm)

0.40 ± 0.06

0.34 ± 0.29

9.00 ± 1.84 *

Range of Tissue Weight (gm)

0.22–0.59

0.08–0.53

4.21–12.44 *

Total Cells (in million)

2.22 ± 0.69

2.82 ± 1.43

6.03 ± 0.54 *

* statistically significant differences between adult subcutaneous tissue group and reproductive tissue groups (p < 0.05)
# statistically significant differences between pediatric reproductive tissue and adult donor tissue collection (p < 0.05)

to a large difference in the sex distribution between the
groups that could not be controlled for.
Harvest Yield

A far greater quantity of tissue was obtained from the
subcutaneous procedure with an average of 9 g of tissue
obtained from each animal with a large range of values
dependent on the surgical procedure at the time of fat
procurement and the preference of the individual veterinarian (Table 1). Approximately 20 times less tissue by
weight could be obtained from the adipose tissue surrounding the reproductive organs, regardless of the age
of the donor. Interestingly there was no difference in the
amount of fat retrieved from the reproductive organs of
young or old cats. Tissue harvested from the

subcutaneous region of each donor was separated into
mechanical or enzymatic digestion. Dual digestion protocols could not be tested using the reproductive fat,
due to the limited amount of tissue obtained from each
donor. Thus, all reproductive fat samples were enzymatically digested.
While more total tissue was obtained from the subcutaneous region, the yield of live MSCs per gram of tissue was greater for the reproductive fat. Figure 1
illustrates the vast difference in the yield per gram of tissue in the reproductive fat versus the subcutaneous tissue samples, regardless of the age of the reproductive fat
donor. To determine whether a different digestion
method could rescue the poor live cell yield in the subcutaneous group, we took samples of subcutaneous fat

Fig. 1 Yield of isolated MSCs from adipose tissue. Following adhesion to plastic, the MCSs were counted and the value divided by the initial
weight of the tissue for that sample to obtain the yield. The adipose tissue surrounding the reproductive organs had the highest density of cells
per gram of tissue regardless of the age of the donor. * indicates statistical differences (p < 0.05) compared to the other groups.
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and mechanically digested it. The method of tissue digestion did not alter the results, with mechanical digestion demonstrating the fewest MSCs per tissue weight
compared to the two reproductive groups, but no difference than the enzymatically digested subcutaneous samples. Even with the lower density of cells, the vastly
larger amount of starting material retrieved from the
subcutaneous fat samples still resulted in a larger total
number of cells (Table 1).
Harvest Viability and Morphology

Fat cells were plated and 24 h later, the adherent
cells were analyzed for viability and morphology. Initial viability following enzymatic digestion of reproductive adipose tissue resulted in over 85 % live cells
for both pediatric and adult tissue donors (Fig. 2). In
contrast, there was a statistically significant decrease
in viability of cells isolated from the subcutaneous tissue. The viability of the cells obtained from subcutaneous fat was approximately 35 % for the mechanical
digestion group, while the value was near 55 % for
the enzymatic digestion procedure.
Cells from the two harvest sites adhered well to plastic
and formed highly homogenous monolayers. All cells
took on the expected fibroblast-like spindle appearance
(Fig. 3) with the cells from reproductive fat showing the
most consistency in shape. There were no noticeable
morphological differences between the subcutaneous fat
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that was enzymatically digested versus mechanical
digestion.
Biomarker Expression

Assessment of the extracted RNA demonstrated acceptable quality and concentrations of RNA samples from all
groups (Table 2). However, due to limited starting tissue
from the reproductive samples, PCR was run on pooled
reproductive samples (pediatric and adult). RNA quality
met the anticipated 260/280 ratio of > 1.9 for all 3
groups. The 260/230 ratios were less than the anticipated 2.0 but were not statistically different. Verification
that the starting material was comprised of MSCs was
conducted by examining expression of classic MSC biomarkers using methods previously published [19, 20].
Figure 4 A summarizes the results with high levels of expression of the MSC biomarkers CD73, CD90 and
CD105. While CD73 was expressed in the lowest
amounts compared to CD90 and CD105, the reproductive fat had the highest expression level of CD73 (lowest
ΔCt value). Subcutaneous enzymatically digested tissue
had the highest expression level of CD90. The raw Ct
values are provided in supplemental Table 1, confirming
the higher expression levels of CD90 and CD105 in all
samples. Fragments were run on gels to confirm the correct size (Fig. 4B). The resulting PCR products were
purified and sent to Genewiz for sequencing. All results
matched the expected sequences and sizes (Table 3).

Fig. 2 Initial viability of the isolated MSCs. MSCs isolated from reproductive adipose tissue demonstrated significantly higher percentage of viable
cells when compared to MSCs isolated from subcutaneous adipose tissue digested either enzymatically or mechanically. * indicates statistical
differences (p < 0.05) compared to the reproductive enzymatically-digested groups.
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Fig. 3 Cell morphology. Following digestion, plated cells that adhered to plastic were cultured to confluency. There were no obvious differences
between the groups, although cells from the reproductive group had the most consistent appearance. Scale bar = 200 μm

In order to assess differences in the multipotency of
the cells, we examined the early differentiation markers
GATA4 involved in embryogenesis of the mesoderm
and endoderm [21], GATA6 a mesodermal marker involved in regulation of cell differentiation [22], SOX2 essential for pluripotency maintenance in stem cells [23]
and SOX17 involved in the regulation of embryonic development [24].
Gata4 expression was low in all 3 samples (Fig. 5 A).
with the cells from reproductive fat showing more expression than the other 2 groups (lower ΔCt). As expected, Gata6 expression was high in the feline cells.
The digestion method did affect Gata6 expression as the
enzymatic and the mechanical digestion performed similarly. Sox2 expression was greatest in the cells digested
enzymatically, showing lesser amplification in the mechanically digested samples (Fig. 5 A). Expression of Sox17

followed the same trend as Sox2 expression, demonstrating an increase in expression in the enzymatically
digested tissue. PDX1 is a marker of early human pancreatic development as is typically only detected in late
endoderm differentiation [25]. After failing to detect significant levels of Gata4 in the feline adipose tissue, we
added the analysis of Pdx1 as a negative control. As expected, Pdx1 was detected only after extremely high
cycle numbers, and normalization to Gapdh did not
change the results (Fig. 5 A).
Because both Gata4 and Pdx1 were consistently detected but at high cycle levels (> 35 cycles), the fragment
sizes were evaluated to ensure that they were the correct
size and not primer dimers or contaminants. Figure 5B
provides examples of the amplicons showing the anticipated size for all of the biomarkers with no additional
bands present. The gels were cropped to provide a

Table 2 RNA Assessment. The quantity and quality of RNA obtained from the 3 sources is provided. Ratios near 2 indicate high
quality RNA.
Adipose Source

Digestion Type

RNA Concentration (ng/uL)

260/280 Ratio

260/230 Ratio

Reproductive

Enzymatic

376.2

2.01

1.81

Subcutaneous

Enzymatic

179.6

2.00

1.56

Subcutaneous

Mechanical

352.3

2.00

1.62
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Fig. 4 MSC Biomarker Expression. A) Standard MSC characterization biomarkers were measured via qRT-PCR. The ΔCT values, normalized to the
housekeeping gene Gapdh, showed high expression CD73, CD90 and CD105. * indicates a statistically significant difference between the
reproductive tissue compared to the other two groups. # indicates statistically significant differences between the subcutaneous enzymaticallydigested fat and the other two groups. B) Amplicons were run on gels and typical examples shown here with single bands of the
anticipated sizes.

Table 3 Primer sequences
Primer

Amplicon Size (bp)

Sequence

Gapdh

234

Forward: GCGTGAACCACGAGAAGTAT
Reverse: CAGTAGAAGCAGGGATGATGTT

CD73

112

Forward: CAACATGGGCAACCTGATTTG
Reverse: CCGAATGCCACCTCCATTTA

CD90

130

Forward: CCTCTCTGCCTGATGAAACTAA
Reverse: CAGAGTTCTGGAAGCTCTTAGG

CD105

138

Forward: CCTTTGGCGCCTTCCTTAT
Reverse: GGTTGGTGCTACTGCTTTCT

CD34

199

Forward: ACCATCAAGGGAGAAATCA
Reverse: GTCAGTTCCTCCCCATTAC

Gata4

251

Forward: CCTCTTGCAATGCGGAAAGA
Reverse: GACATCGCACTGACTGAGAAC

Gata6

246

Forward: CTCGACCGCTTGCTATGAAA
Reverse: GCTCGCTGTTCTCAGGATTAG

Sox2

280

Forward: GCAGTACAACTCCATGACCA
Reverse: GTAGTGCTGGGACATGTGAA

Sox17

322

Forward: CCGCACGGAATTTGAACAGTA
Reverse: CCGTTCAAGTGGCAGACAAA

Pdx1

343

Forward: GCTACGCAGCTCTACAAGGA
Reverse: TAGACTTCATCCACGGGAAAGG

standard order for the groups. The full gels are provided
in the supplemental section of this manuscript (Figure
S1). In addition, the amplicons were sequenced showing
a match with the expected results (Table 3). In order to
appreciate the level of expression, the raw Ct values are
provided in Supplemental Table 2.

Cell Culture Expansion

To measure any effects of the different donor characteristics on cell culture expansion, cells were seeded at an
approximate density of 5,000 cells/cm2 and cell expansion measured by population doubling times. Figure 6 A
summarizes the differences in expansion capability for
the four groups. During P1-P3, there were no significant
differences between the groups’ mean doubling time.
Interestingly, all groups showed a trend towards longer
doubling times with subsequent passages, except for the
cells obtained from adult cat subcutaneous tissue and
mechanically digested, which had a slight decrease in
doubling time with each passage.
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Fig. 5 Biomarker Expression. A) Five biomarkers for pluripotency, differentiation and expansion were measured via rtPCR. The ΔCT values,
normalized to the housekeeping gene Gapdh, showed relatively high expression of pluripotent and expansion markers, Gata6, Sox2 and Sox17. *
indicates a statistically significant difference between the reproductive tissue compared to the other two groups. # indicates statistically
significant differences between the subcutaneous enzymatically-digested fat and the other two groups. B) Examples of amplicons with single
bands of the anticipated sizes are shown. The original gels are provided in Supplemental Figure 1. RE = Reproductive Enzymatic Group, SE =
Subcutaneous Enzymatic Group, SM = Subcutaneous Mechanical Group.

Fig. 6 Cell Expansion. A) The doubling time for the 3 groups at P1 shows high variability and no statistical differences between groups. P3
doubling time showed less variability with no statistical differences between or within groups. B) Viability was high for all groups for the P1
passage. With more passages, the reproductive fat groups had the most consistently high viability.

Wysong et al. BMC Veterinary Research

(2021) 17:244

Viability of the cells was measured at the end of each
passage. The cells in these groups showed high viability
with no differences between groups (Fig. 6B).

Discussion
MSCs are becoming increasingly relevant to clinical care
[5] but the outcomes associated with MSC treatment
have shown great inconsistency. Some of the outcome
variability may be due to the altered characteristics associated with the donors such as age and sex and based on
the site of isolation of the initial tissue [26]. Other factors responsible for inducing variability may include the
methods of isolation, the amount of tissue harvested,
and the passage number. In felines, there have been few
studies to compare sources of MSCs and they have focused on comparing bone marrow-derived MSC to adipose MSCs [18]. Further, when working with abdominal
adipose tissue, the exact donor site often is not clarified
in the reports [27, 28]. A unique study design was
undertaken to enhance the translation of the data to the
clinical setting. The tissue was retrieved during veterinary standard procedures, either abdominal surgery or
spaying of female cats and, when possible, the settings
were either licensed clinical veterinary practices or animal shelters.
Obviously, a much greater quantity of adipose tissue
can be harvested from the subcutaneous fat depot as
compared to the reproductive depot. However, the density of MSCs obtained from those regions was vastly different with the tissue surrounding the reproductive
organs resulting in 40 times more MSCs per tissue
weight. Differences in the age of the female cats had no
effect on the yield of cells from reproductive fat. Even
with this great difference in yield (cells per tissue
weight), the overall number of cells obtained was greater
with the subcutaneous harvest due to the large volume
of subcutaneous fat that could be retrieved. However,
subcutaneous cells had an extremely low viability, especially when digested mechanically, along with the slowest P2 doubling time. The range of doubling times
reported here are consistent with some previous publications of feline abdominal adipose tissue [29] but slower
than those reported by others [30, 31].
Only one other group has focused on different fat
depots in felines comparing abdominal from subcutaneous locations [27]. They found that there was no
difference between the two locations in the multipotent markers nor in the ability of the cells to differentiate into mesoderm lineages. However, they did not
identify the exact location of the abdominal fat depot,
thus it is difficult to directly compare their results to
those reported here.
There have been reports suggesting that mechanical
digestion can be advantageous to enzymatic digestion
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when small quantities of MSCs are desired due to its decreased cost and time commitment but with a decreased
yield [32]. We confirmed that the yield for the mechanically digested sample was significantly less than the
other 2 groups and the resulting viability of the cells was
poor (approximately 25 %). While the remaining cells
could be rescued and passaged, the poor initial outcome
indicates that a significantly larger amount of starting
material would be necessary to harvest, if using mechanical digestion.
The quality and amount of RNA extracted from the
groups showed no relevant differences. This is important
because previous studies concluded that fat contains a
high fatty acid content that can interfere with the extraction of pure RNA, indicated by the 260/230 ratio [33].
We were able to confirm the identity of the starting cells
as MSC based on their biomarker signature described by
previous publications [18, 19, 27, 29, 31]. While all three
groups presented with high levels of expression of standard MSC biomarkers, the reproductive fat sample had
the highest level of CD73 while the subcutaneous enzymatic sample had more CD90, although these differences were likely not clinically relevant. We further
investigated the pluripotency and lineage assignment potential to further characterize the tissue using previously
published techniques [19, 27]. While the differences in
expression levels of some of the pluripotent biomarkers
reached statistical significance, the differences were
small and likely not biologically relevant. Importantly, all
of the pluripotency biomarkers were detected at high
CT values, indicating low levels of gene expression.
SOX2 is a master stem cell transcription factor, determining the stemness capacity of cells [23]. While high
levels of expression of SOX2 have been reported in human, monkey and canine abdominal fat previously [34,
35], its detection in feline cells has been variable. Cat
embryos, along with undifferentiated feline neural stem
cells, contain high levels of Sox2 [36–38]. In addition, a
number of labs have shown that induced pluripotent
stem cells derived from feline fibroblasts express Sox2
[39, 40]. In comparison with canine cells, feline amniotic
MSCs showed a much lower expression of Sox2 and less
immunostaining of the protein compared to canine amniotic stem cells [19]. Some have reported the inability
to detect Sox2 or the resulting protein in feline abdominal or subcutaneous adipose MSCs [27, 28]. In contrast,
our results are consistent with those of Lee et al., showing detection of Sox2 in the abdominal adipose tissue
[31]. Unfortunately, ours is the only study to include the
raw Ct values of our results rather than relative values
that provide no indication of the absolute levels.
GATA6 encodes a transcription factor normally found
in MSCs essential to the self-renewal properties of pluripotent cells. Knockdown of GATA6 results in
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suppression of the self-renewal capacity of MSCs [41].
In cats, Gata6 is assumed to be involved in differentiation similar to humans, but that has yet to be examined. Studies have described the presence of Gata6 in
feline induced pluripotent stem cells [42] and in cat embryos [36], but ours is the first study to report the presence of Gata6 in feline adipose MSCs.
SOX17, identified in human adipose derived MSCs
[43], is involved in the capacity of the cells to differentiate into endoderm and eventually to hepatocytes [44] or
pancreatic tissue [33]. Like Gata6, Sox17 has been detected in feline induced pluripotent stem cells [42], but
has not been investigated in feline adipose MSCs. Thus,
this is the first study to identify Sox17 in feline adiposederived MSCs.
GATA4 is found in high levels in human ovaries where
it is associated with sex determination along with ovary
growth and function, but not in adipocytes [45]. GATA4
is involved in differentiation into osteoblasts and development of the heart and has been reported to be
expressed in only 15 % of rat bone marrow-derived
MSCs based on immunohistochemistry [21]. Thus, it
was not surprising that little was detected in the adipose
MSCs. In fact, minimal expression confirmed that ovarian tissue did not contaminate the reproductive fat
group. Likewise, PDX1 is a biomarker of pancreatic development and is farther down the differentiation
lineage. We included Pdx1 detection as a negative control, thus the lack of Pdx1 was expected.
A major limitation of the study was the fact that because the reproductive fat was obtained during spaying,
there was a difference in the sex distribution between
groups. Based on a clinically relevant study design that
collected excess tissue from standard procedures on predominantly community dwelling cats, sex could not be
controlled for as a variable. A much larger clinical study
is warranted to determine possible sex-based differences.
In addition, this study did not analyze the purity or differentiation capacity of the cells at any of the passages.
While cells from all three groups studied here had
similar pluripotency profiles, the improved yield
(cells/tissue weight) and initial cell viability was dramatically better for the cells harvested from the reproductive tissue, which can be harvested ethically
during spaying procedures. If the goal is an autologous product, then reproductive fat harvests would
not be appropriate, but the field is quickly moving toward the allogeneic model. Consequently, fat surrounding the reproductive organs may offer a
consistently high-quality source of MSCs. In addition,
we showed that enzymatic digestion was the best approach for subcutaneous tissue and the only option
available when working with reproductive tissue due
to the small amount of starting material.
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Conclusions
In conclusion, the work summarized here demonstrates
that feline reproductive adipose tissue is a reasonable
source of MSCs to be cultured for eventual therapeutic
application compared to a subcutaneous fat depot. The
age of the donor did not affect the quality of the MSCs
from the reproductive fat. The MSCs should be isolated
via predominantly enzymatic digestion, but further research should be done to continue optimizing a digestion protocol. For example, in certain clinical situations,
long-term cell culture may not be possible and
mechanically-digested subcutaneous fat may be the only
option. In addition, further research should continue to
further characterize feline adipose-derived MSC, including the differentiation potentials.
Methods
Adipose Tissue Collection

The adipose tissue was collected from 34 healthy female
cats, including cats undergoing spaying at local animal
shelters and the discarded tissue removed during spaying
(the ovaries and uterine horn) was collected and the fat
dissected. Subcutaneous fat was removed from male and
female cats under anesthesia for unrelated surgical procedures. Additionally, two samples were obtained from
research animals undergoing euthanasia (sodium pentobarbital) at the completion of an unrelated study. The
University of Kansas Medical Center’s IACUC determined that tissue removed during spaying or after euthanasia was exempt from required protocol approval.
As all tissue collected would otherwise have been discarded, no consent was necessary. The licensed veterinarians overseeing the animals approved the collection
of the discarded tissue. No exclusion criteria were set for
the study. Table 1 summarizes the donor characteristics.
All donors were standard long or shorthair cats and
were fully immunized at the time of tissue retrieval. Due
to the fact that tissue was retrieved during other procedures, the site of tissue collection (reproductive versus
subcutaneous) could not be randomized. Group assignments were based on convenience of the surgical procedures completed through the duration of the study. Due
to large differences in the tissue mass obtained from the
different sites, blinding of the initial sample groups could
not be done. Analysis of the later passages was completed in a blinded fashion. Donor characteristics were
provided by the attending veterinarian and included age,
weight, sex, body condition, vaccination history, and
general health status including feline leukemia virus
results.
For subcutaneous fat collection, donors were positioned in dorsal recumbency and the surgical site was
prepared using standard aseptic surgical procedures. A
1 cm length incision was made at the midline to allow
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access to fat deposits in the ventral abdomen. Using a
Tulip multi-port tissue harvester cannula attached to a
60CC syringe the abdominal fat was broken up with
gentle back and forth movement of the cannula device.
The syringe was then used to draw out the fat tissue that
was transferred to collection media, consisting of Dulbecco’s Modified Eagle’s Medium (DMEM) supplemented with 1 % pen strep.
Reproductive adipose tissue was collected aseptically
during standard spaying of healthy cats. The removed
ovaries and uterine horn were placed in chilled transport medium comprised of DMEM/F12 (ThermoFisher, Cat#124,000,024) containing 1 % PenicillinStreptomycin (ThermoFisher, Cat#15,140,122) and
transported to the lab on ice. Under aseptic conditions, the fat was manually dissected from the reproductive organs.
Digestion of Adipose Tissue
Mechanical Digestion

Under aseptic conditions, the tissue was rinsed,
weighed, and minced using sterile scissors. Mechanical digestion involved passing the adipose tissue between two 60 mL syringes connected with an
anaerobic luer-to-luer connector (Tulip, Cat #TP
ATLLLL2.4). Using the 2.4 mm Tulip connector, the
tissue was passed between the two syringes 10 times
and then passed through the smaller 1.2 mm Tulip
connector (Tulip, Cat#TP ATLLLL1.2) another 10
times. The tissue solution was centrifuged at 550xg
for 10 min. The cell pellet was reserved for plating in
DMEM culture medium. The remaining supernatant
was collected and the digestion was repeated twice
more with increasing centrifugation speeds in each
round of digestion (620xg and 690xg, respectively).
The cells from the pellets from each digestion were
collected and counted. The pellets were resuspended
in DMEM:F12 with 10 % FBS (ThermoFisher, Cat
#26,140,087) and 1 % Penicillin-Streptomycin and cultured at 37 °C, 5 % CO2 in a humidified chamber.
Enzymatic Digestion

Under aseptic conditions, the tissue was rinsed, weighed,
and minced using sterile scissors and digested in a 0.6
WU/mL Liberase (Roch, Liberase MNP-S, /cat
#06297790001) for 30 min at 37 °C. For the larger tissue
amounts of subcutaneous fat, the tissue was passed
through a 100 mm filter and centrifuges at 260xg for
5 min. The supernatant was removed and mixed with 5
mL of red blood cell lysis buffer (Millipore Sigma, Cat
#11,814,389,001) followed by centrifugation at 260xg for
5 min. The final supernatant was resuspended in
DMEM:F12 with 10 % FBS and 1 % Penicillin-
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Streptomycin and cultured at 37 °C, 5 % CO2 in a humidified chamber.
Cell Culture

Following digestion, cells were incubated for 48 h at
37 °C and 5 % CO2 after which the non-adherent cells
were removed, and fresh medium was added. The
remaining plastic-adherent cells were trypsinized
(Worthington Cat# 9002-07-7) and re-plated at a density
of 5,000 cells/cm2 into T175 flasks. Cell numbers were
calculated using automated cell counter (EVE; NanoEnTek) at the time of passage and during expansion in
order to calculate the doubling time. Cells were passaged
when they met the requirement of 80–100 % confluency.
Flasks that failed to obtain 80 % confluency were removed from analysis. Images of cultured cells were obtained using an Axio Vert.A1 Inverted microscope
(Zeiss) with a 10X objective. Cells were not cultured beyond 5 passages.
Doubling time was calculated based on a published
protocol [46].
DT ¼ T ln 2= lnðXe=Xb  1Þ
T is time, ln is the natural log, Xb indicates the starting cell number, and Xe indicates the ending cell
number.
Viability

Viability was measured from fluorescence emission
levels of calcein (ThermoFisher, Cat #C3099) and propidium iodide (ThermoFisher, Cat #P3566) on a multimode plate reader (BioTek Cytation 5). Calcein stains
live cell green and PI stains dead cells as red. Viability
was calculated as:
½live cell emission ðgreenÞ=total cells ðgreen
þ redÞ x 100
Trypan blue exclusion staining was also used as a
measure of viability. The cells were dispersed into single
cell suspensions using trypsin and briefly incubated with
Trypan blue. Viability was determined as the ratio of
(live cells / total number of cells) x 100.
Biomarker Expression

Total RNA was extracted from frozen cell pellets of the
digested adipose tissue using the mirVana RNA Extraction kit (ThermoFisher, Cat#AM1560) per the manufacturer’s protocol. RNA quality was assessed using the
NanoDrop 1000 Spectrophotometer (Thermo-Fisher).
Absorbance was read at 230, 260 and 280 nm. The 260/
280 ratio of ~ 2.0 indicates high quality RNA. Likewise, a
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260/230 ratio of between 2.0 and 2.2 indicates a pure
sample.
One µg of total RNA was used to make cDNA using
SuperScript IV Reverse Transcriptase (Invitrogen, Cat
#18,090,010) as per the manufacturer’s protocol using
oligo (dT). Primer sequences for the biomarkers were
determined using BLAST (Table 3) and confirmed via
gel electrophoresis.
The cDNA was run through RT-qPCR on the Applied
Biosystems ViiA7 PCR System using Power SYBR Green
PCR Master Mix (Applied Biosystems, Cat #4,367,659)
using the following protocol: 2 min at 95℃ for initial denaturation, followed by cycling 15 s at 95℃ for denaturation, 10 s at 60℃ for annealing, and 60 s at 70℃ for
extension. This protocol repeated for 49 cycles, followed by
recording a melt curve. All samples were amplified in triplicate. An automatic threshold was utilized and a cut off of
40 cycles was determined to indicate presence or absence
of biomarkers. Negative controls without template were
run to 50 cycles with no amplification. The cycle threshold
values were normalized to Gapdh. To confirm the results,
amplicons were run on gels to confirm the correct sizes. In
addition, the resulting PCR products were purified and sent
to Genewiz for Sanger sequencing. All results matched the
expected sequences and sizes (Table 3).
Statistical Analysis

Data were analyzed using a one-way analysis of variance
(ANOVA) on ranks with post hoc Dunn’s pairwise comparison was performed using SigmaPlot 13.0. P values of
less than 0.05 were considered statistically significant,
noted by symbols in the graphs. Data are presented as
averages ± SEM.
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